Selective Enzyme Targeting
Etoricoxib is a second-generation COX-2 inhibitor. By selectively blocking the COX-2 enzyme responsible for pain and inflammation, it avoids the inhibition of COX-1, which is essential for protecting the gastric mucosa (stomach lining).




